Access Bio, Inc. (KOSDAQ:950130)
South Korea · Delayed Price · Currency is KRW 2,570.00
0.00 (0.00%)
Sep 1, 2026, 3:30 PM KST
Access Bio Market Cap
Access Bio has a market cap or net worth of 90.4 billion as of August 31, 2026. Its market cap has decreased by -51.14% in one year.
Market Cap
90.40B
Enterprise Value
-140.81B
Revenue
23.54B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,570.00
ChartMarket Cap Chart
Since May 30, 2013, Access Bio's market cap has decreased from 269.10B to 90.40B, a decrease of -66.41%. That is a compound annual growth rate of -7.89%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 90.40B | -32.37% |
| Dec 30, 2025 | 133.66B | -26.78% |
| Dec 30, 2024 | 182.55B | -39.72% |
| Dec 28, 2023 | 302.84B | -26.91% |
| Dec 29, 2022 | 414.36B | -27.26% |
| Dec 30, 2021 | 569.63B | -27.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Bio Plus | 212.31B |
| Boditech Med | 206.09B |
| JETEMA, | 174.69B |
| Shinhung | 129.09B |
| Dongbang Medical | 125.18B |
| DRTECH | 80.14B |
| Ray Co., Ltd. | 73.12B |
| Humasis | 70.27B |